Patents by Inventor Simon Goepfert

Simon Goepfert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11976286
    Abstract: A plant cell comprising: (a) a polynucleotide sequence encoding a nitrate reductase polypeptide comprising a contiguous polypeptide sequence of SEQ ID NO: 5 or SEQ ID NO: 7, wherein methionine is substituted for an amino acid that reduces nitrate reductase activity in the plant cell as compared to a control plant cell; (b) a polypeptide sequence encoded by the polynucleotide sequence set forth in (a); or (c) a construct, vector or expression vector comprising the polynucleotide sequence set forth in (b).
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: May 7, 2024
    Assignee: Philip Morris Products S.A.
    Inventors: Lucien Bovet, Prisca Campanoni, Simon Goepfert
  • Publication number: 20230397649
    Abstract: An aerosol-generating substrate for a heated aerosol-generating article is provided, the aerosol-generating substrate including: homogenised tobacco material, the homogenised tobacco material including dried green tobacco material, an aerosol former, and a binder, the homogenised tobacco material having an aerosol former content of between 5 percent and 55 percent by weight on a dry weight basis. A dried green tobacco material for forming an aerosol-generating substrate for an aerosol-generating article, and a method of producing dried green tobacco material for the aerosol-generating substrate, are also provided.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 14, 2023
    Applicant: Philip Morris Products S.A.
    Inventors: Lucien BOVET, Simon GOEPFERT, Aurore HILFIKER, Delphine LANGLET
  • Patent number: 11685929
    Abstract: There is described herein a mutant, non-naturally occurring or transgenic plant or part thereof having reduced expression of the gene encoding Terminal Flower 1 (TFL1) or reduced activity of the protein encoded by TFL1, said TFL1 comprising, consisting or consisting essentially of (i) a polynucleotide sequence comprising, consisting or consisting essentially of a sequence having at least 72% sequence identity to SEQ ID NO:7 or SEQ ID NO:8 or SEQ ID NO:10 or SEQ ID NO:11 or SEQ ID NO:19 or SEQ ID NO:20; or (ii) a polypeptide encoded by the polynucleotide set forth in (i); or (iii) a polypeptide having at least 72% sequence identity to SEQ ID NO:9 or SEQ ID NO:12 or SEQ ID NO:21; wherein the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) is reduced as compared to a control plant in which the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) has not been reduced.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: June 27, 2023
    Assignee: Philip Morris Products S.A.
    Inventors: Lucien Bovet, Simon Goepfert, Helene Laparra
  • Publication number: 20220186242
    Abstract: A plant cell comprising: (a) a polynucleotide sequence encoding a nitrate reductase polypeptide comprising a contiguous polypeptide sequence of SEQ ID NO: 5 or SEQ ID NO: 7, wherein methionine is substituted for an amino acid that reduces nitrate reductase activity in the plant cell as compared to a control plant cell; (b) a polypeptide sequence encoded by the polynucleotide sequence set forth in (a); or (c) a construct, vector or expression vector comprising the polynucleotide sequence set forth in (b).
    Type: Application
    Filed: December 16, 2019
    Publication date: June 16, 2022
    Inventors: Lucien Bovet, Prisca Campanoni, Simon Goepfert
  • Publication number: 20200208164
    Abstract: There is described herein a mutant, non-naturally occurring or transgenic plant or part thereof having reduced expression of the gene encoding Terminal Flower 1 (TFL1) or reduced activity of the protein encoded by TFL1, said TFL1 comprising, consisting or consisting essentially of (i) a polynucleotide sequence comprising, consisting or consisting essentially of a sequence having at least 72% sequence identity to SEQ ID NO:7 or SEQ ID NO:8 or SEQ ID NO:10 or SEQ ID NO:11 or SEQ ID NO:19 or SEQ ID NO:20; or (ii) a polypeptide encoded by the polynucleotide set forth in (i); or (iii) a polypeptide having at least 72% sequence identity to SEQ ID NO:9 or SEQ ID NO:12 or SEQ ID NO:21; wherein the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) is reduced as compared to a control plant in which the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) has not been reduced.
    Type: Application
    Filed: December 15, 2017
    Publication date: July 2, 2020
    Inventors: Lucien Bovet, Simon Goepfert, Helene Laparra
  • Patent number: 10415050
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: September 17, 2019
    Assignee: Philip Morris Products S.A.
    Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
  • Patent number: 10287599
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic plant cell comprising: (i) at least one polynucleotide comprising, consisting or consisting essentially of a sequence encoding an isopropylmalate synthase and having at least 60% sequence identity to SEQ ID NO:1 or SEQ ID NO:10 or SEQ ID NO: 12 or SEQ ID NO:14; or (ii) a polypeptide encoded by said polynucleotide(s); or (iii) a polypeptide having at least 60% sequence identity to SEQ ID NO:2 or SEQ ID NO:11 or SEQ ID NO:13 or SEQ ID NO:15; or (iv) a construct, vector or expression vector comprising said polynucleotide sequence(s), optionally wherein said construct, vector or expression vector additionally comprises a promoter comprising, consisting or consisting essentially of the sequence set forth in SEQ ID NO:8 or a variant thereof with at least about 60% identity thereto or a trichome promoter.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: May 14, 2019
    Assignee: Philip Morris Products S.A.
    Inventors: Nicholas Bakaher, Gregor Nicholas Bindler, Michel Philippe Blanc, Simon Goepfert, Florian Martin
  • Publication number: 20170130239
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.
    Type: Application
    Filed: May 7, 2015
    Publication date: May 11, 2017
    Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
  • Publication number: 20140352706
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic plant cell comprising: (i) at least one polynucleotide comprising, consisting or consisting essentially of a sequence encoding an isopropylmalate synthase and having at least 60% sequence identity to SEQ ID NO:1 or SEQ ID NO:10 or SEQ ID NO: 12 or SEQ ID NO:14; or (ii) a polypeptide encoded by said polynucleotide(s); or (iii) a polypeptide having at least 60% sequence identity to SEQ ID NO:2 or SEQ ID NO:11 or SEQ ID NO:13 or SEQ ID NO:15; or (iv) a construct, vector or expression vector comprising said polynucleotide sequence(s), optionally wherein said construct, vector or expression vector additionally comprises a promoter comprising, consisting or consisting essentially of the sequence set forth in SEQ ID NO:8 or a variant thereof with at least about 60% identity thereto or a trichome promoter.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 4, 2014
    Applicant: PHILIP MORRIS PRODUCTS S.A.
    Inventors: Nicholas Bakaher, Gregor Nicholas Bindler, Michel Philippe Blanc, Simon Goepfert, Florian Martin